Secukinumab in Active Rheumatoid Arthritis after Anti-TNFα Therapy: A Randomized, Double-Blind Placebo-Controlled Phase 3 Study

被引：0

作者：

Hasan Tahir

Atul Deodhar

Mark Genovese

Tsutomu Takeuchi

Jacob Aelion

Filip Van den Bosch

Sibylle Haemmerle

Hanno B. Richards

机构：

[1] Barts Health NHS Trust,

[2] Oregon Health and Science University,undefined

[3] Stanford University,undefined

[4] Keio University School of Medicine,undefined

[5] West Tennessee Research Institute,undefined

[6] Ghent University Hospital,undefined

[7] Novartis Pharma AG,undefined

来源：

Rheumatology and Therapy | 2017年 / 4卷

关键词：

ACR; Autoimmune; Biologic; Clinical trial; HAQ-DI; IL-17A; Randomized; Rheumatoid arthritis; Secukinumab; vdH-mTSS;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：475 / 488

页数：13

共 106 条